Novo Integrated Sciences Stock Fundamentals

NVOSDelisted Stock  USD 0.04  0.01  17.57%   
Novo Integrated Sciences fundamentals help investors to digest information that contributes to Novo Integrated's financial success or failures. It also enables traders to predict the movement of Novo OTC Stock. The fundamental analysis module provides a way to measure Novo Integrated's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novo Integrated otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Novo Integrated Sciences OTC Stock Return On Equity Analysis

Novo Integrated's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Novo Integrated Return On Equity

    
  -1.35  
Most of Novo Integrated's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novo Integrated Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Novo Integrated Sciences has a Return On Equity of -1.3542. This is 94.35% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

Novo Integrated Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Novo Integrated's current stock value. Our valuation model uses many indicators to compare Novo Integrated value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novo Integrated competition to find correlations between indicators driving Novo Integrated's intrinsic value. More Info.
Novo Integrated Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novo Integrated's earnings, one of the primary drivers of an investment's value.

Novo Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novo Integrated's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Novo Integrated could also be used in its relative valuation, which is a method of valuing Novo Integrated by comparing valuation metrics of similar companies.
Novo Integrated is currently under evaluation in return on equity category among its peers.

Novo Fundamentals

About Novo Integrated Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Novo Integrated Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novo Integrated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novo Integrated Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc. Novo Integrated operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 73 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Integrated Sciences. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Consideration for investing in Novo OTC Stock

If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device